CLGN Stock Analysis: Buy, Sell, or Hold?
CLGN - CollPlant Biotechnologies Ltd Ordinary Shares
$0.39
0.03 (8.35%)
▲
5d:
+28.96%
30d:
+42.19%
90d:
-3.27%
WAIT
LOW Confidence
Analysis Updated: Aug 31, 2026 12:00 AM ET
Earnings: Sep 02, 2026
TODAY
Get Alerted When CLGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CLGN is 14.1% above its trading range ($0.34). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CLGN is 14.1% above its trading range ($0.34). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CLGN is currently trading at $0.39, which is considered extended relative to its 30-day fair value range of $0.29 to $0.34. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.2) compared to its historical average (3.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CLGN is in a downtrend. Immediate support is located at $0.26, while resistance sits at $0.96. The stock is showing strong short-term momentum, up 8.4% recently.
Market Sentiment: CLGN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.12 (+2766.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLGN is in a downtrend. Immediate support is located at $0.26, while resistance sits at $0.96. The stock is showing strong short-term momentum, up 8.4% recently.
Market Sentiment: CLGN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.12 (+2766.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.29 -
$0.34
Company Quality Score
38/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
23.8%
All Signals
- BEARISH: Price significantly overextended (+14.1% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: Strong upward momentum (+8.4%)
- BULLISH: Trading 2766.7% below Wall St target ($11.12)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.29 -
$0.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.26
Resistance Level
$0.96
Current Trend
Downtrend
Technical data as of
Aug 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.16
Wall Street Target
$11.12
(+2766.7%)
Revenue Growth (YoY)
-96.4%
PE vs Historical
-2.2 vs 3.5
CHEAP
Share & Embed Analysis
Last updated: August 31, 2026 7:44 PM ET
Data refreshes hourly during market hours. Next update: 8:44 PM
Data refreshes hourly during market hours. Next update: 8:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 40 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 41 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$287 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 46 HOLD |
